Curcumae Rhizoma - combined with Sparganii Rhizoma in the treatment of liver cancer: Chemical analysis using UPLC-LTQ-Orbitrap MSn, network analysis, and experimental assessment

• Main Authors: Jing Wei (Author), Xiaoping Wang (Author), Ying Dong (Author), Xiangjian Zhong (Author), Xueyang Ren (Author), Ruolan Song (Author), Jiamu Ma (Author), Axiang Yu (Author), Qiqi Fan (Author), Jianling Yao (Author), Dongjie Shan (Author), Fang Lv (Author), Yuan Zheng (Author), Qingyue Deng (Author), Xianxian Li (Author), Yingyu He (Author), Shusheng Fan (Author), Chongjun Zhao (Author), Xiuhuan Wang (Author), Ruijuan Yuan (Author), Gaimei She (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective:Curcumae Rhizoma-Sparganii Rhizoma (CR-SR) is a traditional botanical drug pair that can promote blood circulation, remove blood stasis, and treat tumors in clinics. The aim of the present study was to investigate the therapeutic material basis and potential mechanisms of CR-SR, CR, and SR...